$38.19
6.20% yesterday
Nasdaq, Oct 15, 10:02 pm CET
ISIN
US04280A1007
Symbol
ARWR

Arrowhead Pharmaceuticals, Inc. Stock price

$38.19
+9.52 33.21% 1M
+25.32 196.74% 6M
+19.39 103.14% YTD
+18.31 92.10% 1Y
+4.20 12.36% 3Y
-10.66 21.82% 5Y
+32.69 594.36% 10Y
+7.69 25.21% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+2.23 6.20%

Key metrics

Basic
Market capitalization
$5.3b
Enterprise Value
$5.0b
Net debt
positive
Cash
$898.2m
Shares outstanding
138.1m
Valuation (TTM | estimate)
P/E
negative | 306.3
P/S
9.2 | 6.9
EV/Sales
8.7 | 6.5
EV/FCF
negative
P/B
10.1
Financial Health
Equity Ratio
16.3%
Return on Equity
-323.3%
ROCE
-9.1%
ROIC
-26.1%
Debt/Equity
1.1
Financials (TTM | estimate)
Revenue
$573.0m | $764.2m
EBITDA
$-85.4m | $82.8m
EBIT
$-108.0m | $59.1m
Net Income
$-148.4m | $17.2m
Free Cash Flow
$-17.6m
Growth (TTM | estimate)
Revenue
2,815.9% | 21,427.3%
EBITDA
83.9% | 114.2%
EBIT
80.3% | 109.8%
Net Income
72.4% | 102.9%
Free Cash Flow
96.7%
Margin (TTM | estimate)
Gross
-
EBITDA
-14.9% | 10.8%
EBIT
-18.8%
Net
-25.9% | 2.3%
Free Cash Flow
-3.1%
More
EPS
$-1.1
FCF per Share
$-0.1
Short interest
10.9%
Employees
609
Rev per Employee
$10.0k
Show more

Is Arrowhead Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Arrowhead Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Arrowhead Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
573 573
2,816% 2,816%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 123 123
14% 14%
21%
- Research and Development Expense 536 536
21% 21%
93%
-85 -85
84% 84%
-15%
- Depreciation and Amortization 23 23
29% 29%
4%
EBIT (Operating Income) EBIT -108 -108
80% 80%
-19%
Net Profit -148 -148
72% 72%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Arrowhead Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arrowhead Pharmaceuticals, Inc. Stock News

Neutral
Business Wire
9 days ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-DIMER-PA, the company's investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for atherosclerotic cardiovascular disease (ASCVD) due to mixed hyperlip...
Neutral
Business Wire
about one month ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for the District of Delaware against Ionis Pharmaceuticals, Inc., to declare that Ionis's United States Patent No. 9,593,333 (“the '333 patent”) is invalid and not infringed by Arrowhead's pla...
Neutral
Seeking Alpha
about one month ago
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Dr. Christopher Anzalone - Chairman, CEO & President James Hamilton - Chief Medical Officer and Head of R&D Conference Call Participants Michael Ulz - Morgan Stanley, Research Division Presentation Michael Ulz Equity Analyst All right. Good ...
More Arrowhead Pharmaceuticals, Inc. News

Company Profile

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Head office United States
CEO Christopher Anzalone
Employees 609
Founded 1989
Website arrowheadpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today